Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David T Vodak

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Molecular Pharmaceutics|December 16, 2017
Millisecond Self-Assembly of Stable Nanodispersed Drug FormulationsVikram J Pansare, Aditya Rawal, Aaron Goodwin, et al.
Molecular Pharmaceutics|August 25, 2020
Novel High-Drug-Loaded Amorphous Dispersion Tablets of Posaconazole; <i>In Vivo</i> and <i>In Vitro</i> AssessmentDeanna M Mudie, Aaron M Stewart, Nishant Biswas, et al.
Pharmaceutics|April 30, 2021
Amorphous Solid Dispersion Tablets Overcome Acalabrutinib pH Effect in DogsDeanna M Mudie, Aaron M Stewart, Jesus A Rosales, et al.
Drug Development and Industrial Pharmacy|May 27, 2015
Inhaled PYY(3-36) dry-powder formulation for appetite suppressionPhilip J Kuehl, Tracey Boyden, Dan E Dobry, et al.
Molecular Pharmaceutics|October 31, 2018
Enhancing the Oral Absorption of Kinase Inhibitors Using Lipophilic Salts and Lipid-Based FormulationsHywel D Williams, Leigh Ford, Sifei Han, et al.
AAPS Pharmscitech|August 10, 2014
Biologic comparison of inhaled insulin formulations: Exubera™ and novel spray-dried engineered particles of dextran-10Philip J Kuehl, Alan Cherrington, Dan E Dobry, et al.
AAPS Pharmscitech|September 1, 2021
Local Treatment of Non-small Cell Lung Cancer with a Spray-Dried Bevacizumab FormulationKimberly B Shepard, David T Vodak, Philip J Kuehl, et al.
International Journal of Pharmaceutics: X|March 11, 2020
A novel architecture for achieving high drug loading in amorphous spray dried dispersion tabletsDeanna M Mudie, Stephanie Buchanan, Aaron M Stewart, et al.
British Journal of Cancer|February 28, 2020
5-Azacytidine inhaled dry powder formulation profoundly improves pharmacokinetics and efficacy for lung cancer therapy through genome reprogrammingPhilip J Kuehl, Carmen S Tellez, Marcie J Grimes, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Molecular Pharmaceutics|December 16, 2017
Millisecond Self-Assembly of Stable Nanodispersed Drug FormulationsVikram J Pansare, Aditya Rawal, Aaron Goodwin, et al.
Molecular Pharmaceutics|August 25, 2020
Novel High-Drug-Loaded Amorphous Dispersion Tablets of Posaconazole; <i>In Vivo</i> and <i>In Vitro</i> AssessmentDeanna M Mudie, Aaron M Stewart, Nishant Biswas, et al.
Pharmaceutics|April 30, 2021
Amorphous Solid Dispersion Tablets Overcome Acalabrutinib pH Effect in DogsDeanna M Mudie, Aaron M Stewart, Jesus A Rosales, et al.
Drug Development and Industrial Pharmacy|May 27, 2015
Inhaled PYY(3-36) dry-powder formulation for appetite suppressionPhilip J Kuehl, Tracey Boyden, Dan E Dobry, et al.
Molecular Pharmaceutics|October 31, 2018
Enhancing the Oral Absorption of Kinase Inhibitors Using Lipophilic Salts and Lipid-Based FormulationsHywel D Williams, Leigh Ford, Sifei Han, et al.
AAPS Pharmscitech|August 10, 2014
Biologic comparison of inhaled insulin formulations: Exubera™ and novel spray-dried engineered particles of dextran-10Philip J Kuehl, Alan Cherrington, Dan E Dobry, et al.
AAPS Pharmscitech|September 1, 2021
Local Treatment of Non-small Cell Lung Cancer with a Spray-Dried Bevacizumab FormulationKimberly B Shepard, David T Vodak, Philip J Kuehl, et al.
International Journal of Pharmaceutics: X|March 11, 2020
A novel architecture for achieving high drug loading in amorphous spray dried dispersion tabletsDeanna M Mudie, Stephanie Buchanan, Aaron M Stewart, et al.
British Journal of Cancer|February 28, 2020
5-Azacytidine inhaled dry powder formulation profoundly improves pharmacokinetics and efficacy for lung cancer therapy through genome reprogrammingPhilip J Kuehl, Carmen S Tellez, Marcie J Grimes, et al.
Pageof 2